88 related articles for article (PubMed ID: 6207198)
1. The prognostic value of calcitonin immunostaining in medullary carcinoma of the thyroid.
Saad MF; Ordonez NG; Guido JJ; Samaan NA
J Clin Endocrinol Metab; 1984 Nov; 59(5):850-6. PubMed ID: 6207198
[TBL] [Abstract][Full Text] [Related]
2. Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients.
Saad MF; Ordonez NG; Rashid RK; Guido JJ; Hill CS; Hickey RC; Samaan NA
Medicine (Baltimore); 1984 Nov; 63(6):319-42. PubMed ID: 6503683
[TBL] [Abstract][Full Text] [Related]
3. The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase.
Lippman SM; Mendelsohn G; Trump DL; Wells SA; Baylin SB
J Clin Endocrinol Metab; 1982 Feb; 54(2):233-40. PubMed ID: 6798062
[TBL] [Abstract][Full Text] [Related]
4. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
5. Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin.
Karga H; Giagourta I; Papaioannou G; Doumouchtsis K; Polymeris A; Thanou S; Papamichael K; Zerva C
Metabolism; 2011 May; 60(5):604-8. PubMed ID: 20667564
[TBL] [Abstract][Full Text] [Related]
6. Medullary differentiation of anaplastic thyroid carcinoma.
Nieuwenhuijzen Kruseman AC; Bosman FT; van Bergen Henegouw JC; Cramer-Knijnenburg G; Brutel de la Riviere G
Am J Clin Pathol; 1982 May; 77(5):541-7. PubMed ID: 6177234
[TBL] [Abstract][Full Text] [Related]
7. Medullary thyroid carcinoma: prognosis of familial versus nonfamilial disease and the role of radiotherapy.
Samaan NA; Schultz PN; Hickey RC
Horm Metab Res Suppl; 1989; 21():21-5. PubMed ID: 2807151
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid.
Saad MF; Fritsche HA; Samaan NA
J Clin Endocrinol Metab; 1984 May; 58(5):889-94. PubMed ID: 6707192
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of calcitonin and carcinoembryonic antigen (CEA) in medullary carcinoma of the thyroid (MCT) by immunoperoxidase technique.
Talerman A; Lindeman J; Kievit-Tyson PA; Dröge-Droppert C
Histopathology; 1979 Nov; 3(6):503-10. PubMed ID: 389771
[TBL] [Abstract][Full Text] [Related]
10. Medullary thyroid carcinoma: prognostic factors.
Riddell DA; Lampe HB; Cramer H; Troster M
J Otolaryngol; 1993 Jun; 22(3):180-3. PubMed ID: 7690409
[TBL] [Abstract][Full Text] [Related]
11. Medullary thyroid carcinoma with thyroglobulin immunoreactivity. A special entity?
Holm R; Sobrinho-Simões M; Nesland JM; Sambade C; Johannessen JV
Lab Invest; 1987 Sep; 57(3):258-68. PubMed ID: 3626517
[TBL] [Abstract][Full Text] [Related]
12. Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease.
Mendelsohn G; Wells SA; Baylin SB
Cancer; 1984 Aug; 54(4):657-62. PubMed ID: 6378353
[TBL] [Abstract][Full Text] [Related]
13. Long-term prognosis of medullary thyroid carcinoma.
Rendl G; Manzl M; Hitzl W; Sungler P; Pirich C
Clin Endocrinol (Oxf); 2008 Sep; 69(3):497-505. PubMed ID: 18331612
[TBL] [Abstract][Full Text] [Related]
14. [The prognostic importance of calcitonin screening in familial medullary thyroid carcinoma].
Raue F; Geiger S; Buhr H; Frank-Raue K; Ziegler R
Dtsch Med Wochenschr; 1993 Jan; 118(3):49-52. PubMed ID: 8425457
[TBL] [Abstract][Full Text] [Related]
15. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).
Cohen R; Campos JM; Salaün C; Heshmati HM; Kraimps JL; Proye C; Sarfati E; Henry JF; Niccoli-Sire P; Modigliani E
J Clin Endocrinol Metab; 2000 Feb; 85(2):919-22. PubMed ID: 10690910
[TBL] [Abstract][Full Text] [Related]
16. Carcinoma of the thyroid with a mixed medullary, papillary, follicular, and undifferentiated pattern.
Parker LN; Kollin J; Wu SY; Rypins EB; Juler GL
Arch Intern Med; 1985 Aug; 145(8):1507-9. PubMed ID: 3896182
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of calcitonin immunoreactivity, amyloid staining, and flow cytometric DNA measurements in medullary thyroid carcinoma.
Pyke CM; Hay ID; Goellner JR; Bergstralh EJ; van Heerden JA; Grant CS
Surgery; 1991 Dec; 110(6):964-70; discussion 970-1. PubMed ID: 1745984
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of medullary carcinoma of the thyroid.
Tisell LE; Hansson G; Jansson S
Horm Metab Res Suppl; 1989; 21():29-31. PubMed ID: 2807153
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.
Barbet J; Campion L; Kraeber-Bodéré F; Chatal JF;
J Clin Endocrinol Metab; 2005 Nov; 90(11):6077-84. PubMed ID: 16091497
[TBL] [Abstract][Full Text] [Related]
20. Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapy.
Samaan NA; Schultz PN; Hickey RC
J Clin Endocrinol Metab; 1988 Oct; 67(4):801-5. PubMed ID: 2901430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
